United Therapeutics Acquisitions

United Therapeutics has acquired 4 companies and its latest acquisition was IVIVA Medical, Inc. on Nov 2023

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
IVIVA Medical, Inc.

Nov 2023

Source »
undisclosed
IVIVA is a Massachusetts-based biotechnology company that researches and develops organ therapeutics for the treatment of chronic kidney diseases.
Miromatrix Medical, Inc.

Oct 2023

Source »
$91M
Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.
Priority Review Voucher

Dec 2020

Source »
$105M
-
Steadymed Ltd.

Apr 2018

Source »
$141M
SteadyMed develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension.

Frequently Asked Questions about United Therapeutics

  1. What companies did United Therapeutics acquire?

    Companies acquired by United Therapeutics include IVIVA, Miromatrix and Priority Review Voucher
  2. How many acquisitions does United Therapeutics have?

    United Therapeutics has acquired 4 companies including IVIVA, Miromatrix and Priority Review Voucher.
  1. How many acquisitions did United Therapeutics make in 2023?

    In 2023 United Therapeutics acquired 2 companies including IVIVA and Miromatrix.